Treatments

Research on mesothelioma treatments devoted to your prognosis. Inform yourself on the latest clinical trials and holistic treatments being used now.

Alternatives | Europe | International | New Drugs | Treatments | Updates

Anti-Inflammatory Treatment for Mesothelioma Shows Long-Term Benefit
ByAlex Strauss December 7, 2019December 5, 2019

Doctors in London are reporting a case of long-term mesothelioma survival with anti-inflammatory treatment for mesothelioma. The 64-year-old pleural mesothelioma…

Read More Anti-Inflammatory Treatment for Mesothelioma Shows Long-Term Benefit
Europe | International | Radiation Therapy | Treatments

Drug May Make Mesothelioma Cells More Sensitive to Radiation
ByAlex Strauss December 4, 2019December 3, 2019

Scottish cancer researchers say they have found a way to make mesothelioma cells more sensitive to radiation. Radiotherapy is one…

Read More Drug May Make Mesothelioma Cells More Sensitive to Radiation
Europe | International | New Drugs | New Studies | Research | Treatments

Second-Line Treatment for Mesothelioma with Lurbinectedin
ByAlex Strauss November 13, 2019

Swiss researchers may have finally found an effective second-line treatment for mesothelioma. Scientists with the Swiss Group for Clinical Cancer…

Read More Second-Line Treatment for Mesothelioma with Lurbinectedin
Asia | Chemotherapy | International | Surgery | Treatments

Peritoneal Mesothelioma Surgery with HIPEC Can Trigger Blood Cell Problems
ByAlex Strauss November 10, 2019

More than half of patients who have peritoneal mesothelioma surgery with HIPEC develop problems with their blood cells afterward. That’s…

Read More Peritoneal Mesothelioma Surgery with HIPEC Can Trigger Blood Cell Problems
Genetics | Immunotherapy | New Studies | Research | Treatments

CRISPR Gene Editing Technique and the Future of Mesothelioma Treatment
ByAlex Strauss November 8, 2019

The powerful CRISPR gene editing technique might have a role to play in the future of mesothelioma treatment. CRISPR is…

Read More CRISPR Gene Editing Technique and the Future of Mesothelioma Treatment
Asia | International | Surgery | Treatments

Repeated Mesothelioma Surgeries Credited with Japanese Man’s Survival
ByAlex Strauss October 28, 2019

Can repeated mesothelioma surgeries extend peritoneal mesothelioma survival? A new case report out of Japan suggests the answer may be…

Read More Repeated Mesothelioma Surgeries Credited with Japanese Man’s Survival
Europe | International | New Studies | Research | Surgery | Treatments

Mesothelioma Clinical Trials: Study Highlights Challenges for Patients
ByAlex Strauss October 21, 2019

A new UK study points to some of the potential challenges and benefits for patients involved in mesothelioma clinical trials. …

Read More Mesothelioma Clinical Trials: Study Highlights Challenges for Patients
Europe | International | Multi-Modality Therapy | Surgery | Treatments

Biphasic Mesothelioma Survival Possible in Select Patients
ByAlex Strauss October 15, 2019

A new report contains some hopeful news about biphasic mesothelioma survival. Biphasic mesothelioma is the rarest subtype of a rare…

Read More Biphasic Mesothelioma Survival Possible in Select Patients
Surgery | Symptoms | Treatments

Predicting Opioid Addiction in Mesothelioma Patients
ByAlex Strauss October 5, 2019October 5, 2019

New research suggests that it may be possible to predict which mesothelioma patients are at risk for opioid addiction. The…

Read More Predicting Opioid Addiction in Mesothelioma Patients
Europe | Immunotherapy | International | New Studies | Research | Treatments

Pembrolizumab for Mesothelioma Dealt Setback by New Trial Results
ByAlex Strauss September 30, 2019September 30, 2019

There has been a setback for researchers focused on the promise of pembrolizumab for mesothelioma. New research suggests that pembrolizumab…

Read More Pembrolizumab for Mesothelioma Dealt Setback by New Trial Results

1 (888) 378-1331

Treatments

Anti-Inflammatory Treatment for Mesothelioma Shows Long-Term Benefit

Drug May Make Mesothelioma Cells More Sensitive to Radiation

Second-Line Treatment for Mesothelioma with Lurbinectedin

Peritoneal Mesothelioma Surgery with HIPEC Can Trigger Blood Cell Problems

CRISPR Gene Editing Technique and the Future of Mesothelioma Treatment

Repeated Mesothelioma Surgeries Credited with Japanese Man’s Survival

Mesothelioma Clinical Trials: Study Highlights Challenges for Patients

Biphasic Mesothelioma Survival Possible in Select Patients

Predicting Opioid Addiction in Mesothelioma Patients

Pembrolizumab for Mesothelioma Dealt Setback by New Trial Results

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES